EKF Ekf Diagnostics Holdings Plc

TIDMEKF

RNS Number : 2483K

EKF Diagnostics Holdings PLC

06 July 2017

EKF Diagnostics Holdings plc

("EKF", the "Company")

Trading update

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, provides an update on current trading.

The Company is pleased to announce that the trading in the second quarter of the year has continued the favourable trends experienced in the first quarter.

In particular, June sales were notably strong. This is entirely due to organic growth with no major tenders won during the period.

As a consequence, the Company expects adjusted EBITDA for 2017 will be comfortably ahead of current market forecasts.

Finally, despite the cancellation of the stock option scheme at a cost of GBP1.5m cash generation has been very strong with net cash at 30 June of approximately GBP4.0m.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

 
     EKF Diagnostics Holdings plc                             www.ekfdiagnostics.com 
     Christopher Mills, Non-Executive                             Tel: 029 2071 0570 
      Chairman 
     Julian Baines, CEO 
     Richard Evans, FD & COO 
 
     N+1 Singer (Nomad & Broker)                                  Tel: 020 7496 3000 
     Alex Price / Alex Laughton-Scott 
 
     Walbrook PR Limited                    Tel: 020 7933 8780 or ekf@walbrookpr.com 
     Paul McManus / Lianne Cawthorne                      Mob: 07980 541 893 / 07584 
                                                                             391 303 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLLFLRDTIEIID

(END) Dow Jones Newswires

July 06, 2017 02:00 ET (06:00 GMT)

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From May 2023 to May 2024